Latest News about BLUE
Recent news which mentions BLUE
Motley Fool Co-Founder David Gardner Reviews Stock Picks
July 11, 2025
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
BlueBird Shares Are Up Today: What's Going On?
March 31, 2025
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 31, 2025
From Benzinga
From Benzinga
From Benzinga
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
March 11, 2025
From Benzinga
Dow Tumbles Over 700 Points; US Services PMI Falls In February
February 21, 2025
From Benzinga
What's Going On With Gene Therapy Company Bluebird Bio Stock Today?
February 21, 2025
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 05, 2024
From Benzinga
Why Verint Systems Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
December 05, 2024
From Benzinga
FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program
December 04, 2024
From Benzinga
FDA Probes Potential Life-Threatening Blood Cancer Risks Linked To Bluebird Bio's Skysona Gene Therapy
November 29, 2024
From Benzinga
JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options
November 15, 2024
From Benzinga
Earnings Scheduled For November 14, 2024
November 14, 2024
From Benzinga
Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy
October 11, 2024
From Benzinga
The Analyst Verdict: bluebird bio In The Eyes Of 5 Experts
September 25, 2024
Tickers
BLUE
From Benzinga
Gene Therapy-Focused Bluebird Bio Restructures, Cuts Is Workforce By 25%, Seeks To Breakeven Next Year
September 24, 2024
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
Better Buy: Bluebird Bio Vs. Novavax
April 13, 2024
From Motley Fool
Tickers
BLUE
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.